[1]周相军　朱娜娜　李　浩.血清TGF-β、VTN水平与成人脑胶质瘤病理分级及预后的关系[J].中国临床神经外科杂志,2019,(12):727-729.[doi:10.13798/j.issn.1009-153X.2019.12.003]
　ZHOU Xiang-jun,ZHU Na-na,LI Hao..Relationship of serum levels of TGF-β and VTN with pathological grade of tumors and prognosis in adult patients with cerebral gliomas[J].,2019,(12):727-729.[doi:10.13798/j.issn.1009-153X.2019.12.003]
点击复制

血清TGF-β、VTN水平与成人脑胶质瘤病理分级及预后的关系()
分享到：

《中国临床神经外科杂志》[ISSN:1009-153X/CN:42-1603/TN]

卷:
期数:
2019年12期
页码:
727-729
栏目:
论著
出版日期:
2019-12-24

文章信息/Info

Title:
Relationship of serum levels of TGF-β and VTN with pathological grade of tumors and prognosis in adult patients with cerebral gliomas
文章编号:
1009-153X（2019）12-0727-03
作者:
周相军　朱娜娜　李　浩
464000 河南，信阳市中心医院神经外科（周相军、李　浩），消毒供应中心（朱娜娜）
Author(s):
ZHOU Xiang-jun1;  ZHU Na-na2;  LI Hao1.
1. Department of Neurosurgery, Xinyang Municipal Central Hospital, Xinyang 464000, China; 2. Disinfection and Supply Room, Xinyang Municipal Central Hospital, Xinyang 464000, China
关键词:
脑胶质瘤; 转化生长因子-β; 玻连蛋白; 血清水平; 预后
Keywords:
Brain gliomas;  Transforming growth factor-β;  Vitronectin;  Prognosis;  Serum levels
分类号:
R 739.41; Q 786
DOI:
10.13798/j.issn.1009-153X.2019.12.003
文献标志码:
A
摘要:
目的 探讨外周血转化生长因子-β（TGF-β）、玻连蛋白（VTN）水平与成人脑胶质瘤病理分级及预后的关系。方法 选取2015年1月至2016年1月手术治疗的胶质瘤98例（高级别53例，低级别45例）和同期健康体检者50例（对照组）为研究对象，术前1 d、术后 7 d检测血清TGF-β、VTN水平。术后随访3年。结果 术前1 d胶质瘤病人血清TGF-β、VTN水平均显著高于对照组（P<0.05），而且术前1 d血清TGF-β（r=0.734，P<0.05）、VTN（r=0.717，P<0.05）水平与胶质瘤病理分级呈正相关。术后3年，98例胶质瘤中，死亡69例，存活29例；存活病人术前血清TGF-β、VTN水平均显著低于死亡病人（P<0.05）；ROC曲线分析结果显示术前1 d血清TGF-β、VTN水平预测术后3年病人死亡风险的最佳截断值分别为350.39 pg/ml、86.12 μg/ml。结论 胶质瘤病人血清TGF-β、VTN水平与肿瘤病理分级正相关，而且血清TGF-β、VTN水平升高提示病人预后不良。
Abstract:
Objective To analyze relationship of serum levels of transforming growth factor-β (TGF-β) and vitronectin (VTN) with the pathological grade of the tumors and prognosis in adult patients with cerebral gliomas. Methods The serum levels of TGF-β and VTN were determined in the 98 adult patients with cerebral gliomas who were treated by surgery in our hospital from January, 2015 to January, 2016 and 50 healthful subjects. Of 98 patients with cerebral gliomas, 11 had WHO grade I gliomas, 42 grade II, 27 grade III and 18 grade IV. The relationships of postoperative serum level of TGF-β and VTN with WHO pathological grade of brain gliomas and the patients prognosis were analyzed. Results The serum levels of TGF-β and VTN were significantly higher in the patients with WHO grades Ⅲ and Ⅳ brain gliomas than those in the patients with WHO grades I and Ⅱ (P<0.05). The serum levels of TGF-β (r=0.734, P<0.05) and VTN (r=0.717, P<0.05) were positively correlated with WHO pathological grade of brain glioma. The cut-off values of TGF-β and VTN for predicting prognosis in the patients with gliomas were 350.39 pg/ml and 86.12 μg/ml, respectively. Conclusions The serum levels of TGF-β and VTN in the patients with brain gliomas are positively correlated with WHO pathological grade in the tumors. The increase of the serum TGF-β or VTN levels suggests poor prognosis in the patients with cerebral gliomas.

参考文献/References:

[1] 汪超甲，王　辉. 脑胶质瘤化疗现状及耐药机制的研究进 展[J]. 中国临床神经外科杂志，2017，22（11）：791-794.

[2] 张水仙，刘　丹，李　飞，等. 脑胶质瘤的循环生物标志物 研究进展[J]. 中国临床神经外科杂志，2018，23（12）：61- 63.
[3] Moon H, Ju HL, Chung SI, et al. Transforming growth factor beta promotes liver tumorigenesis in mice via upregulation of snail [J]. Gastroenterology, 2017, 153(5): 1378-1391.
[4] Borthwick LA, Gardner A, Soyza AD, et al. Transforming growth factor-β1 (TGF-β1) driven epithelial to mesenchy- mal transition (EMT) is accentuated by tumour necrosis factor α (TNF α) via crosstalk between the SMAD and NF- κB pathways [J]. Cancer Microenviron, 2012, 5(1): 45-57.
[5] Hashimoto K, Ikeda N, Nakashima M, et al. Vitronectin re- gulates the fibrinolytic system during the repair of cerebral cortex in stab-wounded mice[J]. J Neurotrauma, 2017, 34 (22):3183-3191.
[6] 李凯新，孔　月，董百强，等. 放疗联合替莫唑胺治疗术后 高级别脑胶质瘤的临床分析[J]. 中华放射肿瘤学杂志， 2017，26(2):84-85.
[7] Ishida CT, Bianchetti E, Shu C, et al. BH3-mimetics and BET-inhibitors elicit enhanced lethality in malignant glioma [J]. Oncotarget, 2017, 8(18): 29558-29573.
[8] Preuss M, Werner P, Barthel H, et al. Integrated PET/MRI for planning navigated biopsies in pediatric brain tumors [J]. Childs Nerv Syst, 2014, 30(8): 1399-1403.
[9] Wheeler SE, Lee NY. Emerging roles of transforming growth factor β signaling in diabetic retinopathy [J]. J Cellul Physiol, 2016, 232(3): 486-489.
[10] Dieterich LC, Mellberg S, Langenkamp E, et al. Transcrip- tional profiling of human glioblastoma vessels indicates a key role of VEGF-A and TGF?22 in vascular abnormaliza- tion [J]. J Pathol, 2015, 228(3): 378-390.
[11] 梁晓芸，李文学，陈建玲，等. 玻连蛋白促进肝癌细胞株增 殖及迁移的初步研究[J]. 癌变·畸变·突变，2014，26（1）： 30-34，39.
[12] 袁　方，李　伟，刘丙丽，等. 恶性脑胶质瘤同步放化疗后 血清TGF-β和GFAP浓度变化及其临床意义[J]. 实用癌 症杂志，2017，33（5）：722-724，734.
[13] 张　波，王　宇. 脑胶质瘤术后放疗患者预后影响因素分 析[J]. 现代中西医结合杂志，2016，25（18）：2011-2013.
[14] 李钦涛，齐平建，董虹廷. 恶性脑胶质瘤患者VEGF及 TGF-β的表达改变及其对瘤体可完整切除的判断价值 [J]. 中华神经医学杂志，2018，17（1）：68-72.
[15] 张极星，张淑荣，赵　亮，等. 老年脑恶性胶质瘤患者血清 TGF-β和GFAP的表达及与临床预后的关系[J]. 中国老 年学杂志，2018，38（20）：4910-4912.

相似文献/References:

[1]付　锴　江普查　宫　睿　王　伟.表达VASH1基因的人脑胶质瘤U-87MG细胞对化疗药物敏感性的变化[J].中国临床神经外科杂志,2016,(01):34.[doi:10.13798/j.issn.1009-153X.2016.01.012]
　FU Kai,JIANG Pu-cha,GONG Rui,et al.Effect of lentiviral vector-mediated VASH1 gene on chemosensitivity of human glioma U-87MG cells[J].,2016,(12):34.[doi:10.13798/j.issn.1009-153X.2016.01.012]
[2]崔焕喜,柳　琛.多模态MRI、神经导航和超声在脑胶质瘤术中的应用[J].中国临床神经外科杂志,2016,(11):721.[doi:10.13798/j.issn.1009-153X.2016.11.027]
[3]闫　珊　徐善才.多学科护理照顾模式对脑胶质瘤术后病人自我护理能力的影响[J].中国临床神经外科杂志,2017,(05):352.[doi:10.13798/j.issn.1009-153X.2017.05.026]
　YAN Shan,XU Shan-cai..Effects of multi-subjects nursing care model on self-care ability in patients with brain glioma after operation[J].,2017,(12):352.[doi:10.13798/j.issn.1009-153X.2017.05.026]
[4]罗似亮　夏之柏.脑胶质瘤病人脑脊液Midkine表达的临床意义[J].中国临床神经外科杂志,2017,(06):416.[doi:10.13798/j.issn.1009-153X.2017.06.017]
　LUO Si-liang,XIA Zhi-bo..Clinical meanings of midkine expression in cerebrospinal fluid of patients with gliomas[J].,2017,(12):416.[doi:10.13798/j.issn.1009-153X.2017.06.017]
[5]呼铁民　褚会松　田　甜　王昆鹏　杨国军　杨立军　王维兴.脑胶质瘤ADAM17与EGFR的表达及临床意义[J].中国临床神经外科杂志,2017,(08):557.[doi:10.13798/j.issn.1009-153X.2017.08.012]
　HU Tie-min,CHU Hui-song,TIAN Tian,et al.Expressions of ADAM17 and EGFR in gliomas tissues and their clinical meanings[J].,2017,(12):557.[doi:10.13798/j.issn.1009-153X.2017.08.012]
[6]汪超甲 综述　王　辉 审校.脑胶质瘤化疗现状及耐药机制的研究进展[J].中国临床神经外科杂志,2017,(11):791.[doi:10.13798/j.issn.1009-153X.2017.11.023]
[7]高剑峰　姚庆和　李晓辉　龙宇波　陈振波.脑胶质瘤miR-9、PPARγ表达水平及临床意义[J].中国临床神经外科杂志,2018,(01):17.[doi:10.13798/j.issn.1009-153X.2018.01.006]
　GAO Jian-feng,YAO Qing-he,LI Xiao-hui,et al.Expressions of miR-9 and PPARγ in human brain gliomas and their clinical meanings[J].,2018,(12):17.[doi:10.13798/j.issn.1009-153X.2018.01.006]
[8]刘　靖　吴立权　黄书岚.聚焦解决模式对脑胶质瘤术后病人自我管理效能感及生命意义的影响[J].中国临床神经外科杂志,2018,(03):208.[doi:10.13798/j.issn.1009-153X.2018.03.025]
　LIU Jing,WU Li-quan,HUANG Shu-lan..Effects of solution focused intervention on self-management efficacy and meanings of life in the patients with gliomas after surgery[J].,2018,(12):208.[doi:10.13798/j.issn.1009-153X.2018.03.025]
[9]刘　炎　杭春华.脑胶质瘤卒中误诊为脑动静脉畸形并出血1例[J].中国临床神经外科杂志,2018,(06):448.[doi:10.13798/j.issn.1009-153X.2018.06.025]
[10]刘东明　胡新华　刘　永　陈　玖　刘宏毅.脑胶质瘤病人静息态默认模式网络研究进展[J].中国临床神经外科杂志,2018,(12):821.[doi:10.13798/j.issn.1009-153X.2018.12.022]

备注/Memo

备注/Memo:
（2019-03-28收稿，2019-07-10修回）
更新日期/Last Update: 2019-12-23